Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)
- Conditions
- Hematological MalignancyPalliative CarePlatelet Transfusion
- Registration Number
- NCT03806712
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Brief Summary
Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in those diseases or its treatments. Yet, a few studies was interested in, whereas platelet transfusion is the only treatment indicated. As it represent a scarce, limited resource, the ethical principles are in conflict in this setting and there's a lack of recommendation. The final decision is take by the clinician and his patient, but no study exist in representation of the two parts. We provide a qualitative study to understand what this decision is made of.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
- major patient
- patient with advanced hematological malignancies
- patient transfused in platelet regularly (3 time at least in last month)
- medical practioner, hematologist, prescribing platelet transfusion at least one per week.
- nurse working in hematology, practicing platelet transfusion at lest one peer week.
- minor patient
- non communicant patient
- non transfused platelet patient
- non voluntary patient or hematologist or nurses
- non graduated hematologist
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method measure the impact of social representation on platelet transfusion practice 3 months inner core and peripheral items of platelet transfusion of each participant will be collected until reaching saturation, it's to say that the repetition of some terms will be measured between each interview thank's to a questionnaire of at least two principals opened questions.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Moracchini
🇫🇷Besançon, France
Moracchini🇫🇷Besançon, France